Abstract
Exon 19 deletions and the exon 21 L858R mutation of the epidermal growth factor receptor gene (EGFR) predict activity of EGFR tyrosine kinase inhibitors, including erlotinib; however, the ability of less common EGFR mutations to predict efficacy of erlotinib is unclear. The efficacy of erlotinib in individual patients with rare EGFR mutations from the MERIT, SATURN, TITAN, TRUST, ATLAS, BeTa, and FASTACT-2 trials was analyzed and compared with data from the literature. In the patients tested for biomarkers, the frequency of rare mutations identified here ranged from 1.7% (eight of 467) in the SATURN study to 7.4% (27 of 364) in ATLAS. Some rare mutations were associated with greater clinical benefit from EGFR tyrosine kinase inhibitor therapy or improved prognosis independent of treatment, whereas others appeared to have a poorer prognosis. In particular, exon 18 G719 mutations, exon 19 K757R and E746G mutations, the exon 20 S768I mutation, and the exon 21 G836S mutation appeared to confer a good outcome with erlotinib treatment, whereas exon 18 S720I showed a particularly poor outcome. Owing to the small number of patients with each mutation, however, it is difficult to confirm whether these rare mutations do indeed confer sen...Continue Reading
References
Feb 16, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sae-Won HanNoe Kyeong Kim
May 18, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Teh-Ying ChouChun-Ming Tsai
Jul 15, 2005·The New England Journal of Medicine·Frances A ShepherdUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Dec 6, 2008·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Claus-Peter SchneiderMartin Reck
Jan 17, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rama Krishna KanchaJustus Duyster
Aug 15, 2009·Oncogene·A F Gazdar
May 25, 2010·The Lancet Oncology·Federico CappuzzoUNKNOWN SATURN investigators
Jun 5, 2010·Japanese Journal of Clinical Oncology·Katsuhiro MasagoMichiaki Mishima
Aug 26, 2010·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Martin ReckDavid Heigener
May 3, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jenn-Yu WuPan-Chyr Yang
May 31, 2011·Lancet·Roy S HerbstJohn Hainsworth
Jul 26, 2011·The Lancet Oncology·Caicun ZhouChangxuan You
Aug 16, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Tommaso De PasMassimo Barberis
Oct 5, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Wolfram BruggerFederico Cappuzzo
Jan 27, 2012·The Lancet Oncology·Tudor CiuleanuEmilio Esteban Gonzalez
Jan 31, 2012·The Lancet Oncology·Rafael RosellUNKNOWN Spanish Lung Cancer Group in collaboration with Groupe Français de Pneumo-Cancérologie and Associazione Italiana Oncologia T
Aug 17, 2012·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Marius Lund-IversenOdd Terje Brustugun
Jan 19, 2013·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Geoffrey R OxnardPasi A Jänne
Jan 25, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Paul YehLeora Horn
Mar 15, 2013·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Erminia MassarelliVassiliki Papadimitrakopoulou
Jun 21, 2013·The Lancet Oncology·Yi-Long WuTony Mok
Oct 9, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce E JohnsonVincent Miller
Jan 7, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Anthony W H ChanKa Fai To
Jan 15, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Satoshi WatanabeKunihiko Kobayashi
Feb 27, 2014·The Journal of Clinical Investigation·Marcin ImielinskiDavid P Carbone
Oct 4, 2014·SpringerPlus·Abed AgbaryaFlavio Lejbkowicz
Dec 17, 2014·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Jin Ho BaekKeunchil Park
Dec 19, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Lalit PallanPek Koh
Jan 7, 2015·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Oscar ArrietaUNKNOWN CLICaP
Feb 11, 2015·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Chao-Hua ChiuJames Chih-Hsin Yang
May 12, 2015·OncoTargets and Therapy·Liang PengShunchang Jiao
Jun 9, 2015·The Lancet Oncology·James C-H YangYi-Long Wu
Jun 23, 2015·Cancer·J NaidooH A Yu
Citations
Jun 28, 2016·Expert Review of Molecular Diagnostics·Yuan TangWeiping Liu
Jun 21, 2016·Cancer Science·Yoshihisa Kobayashi, Tetsuya Mitsudomi
Oct 27, 2017·Nature Reviews. Cancer·Julia Rotow, Trever G Bivona
Dec 23, 2017·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Hua-Li LiuQi-Bin Song
Oct 25, 2017·Cancer Chemotherapy and Pharmacology·Kaiyan ChenYun Fan
Oct 13, 2018·Asia-Pacific Journal of Clinical Oncology·Shengyu ZhouYuankai Shi
Nov 9, 2018·Future Oncology·Shinji KohsakaMakoto Maemondo
Feb 6, 2019·Journal of Cellular Biochemistry·Tao ShenYunfeng Li
Mar 9, 2018·BMC Bioinformatics·Bin ZouHong Yan
Jun 5, 2020·The Journal of International Medical Research·Yangyang CaiKewei Ma
Jun 9, 2020·Briefings in Bioinformatics·Pora KimZhongming Zhao
Mar 30, 2017·International Journal of Oncology·Gou YamamotoKiwamu Akagi
Jul 30, 2018·Cancer Communications·Xiangyang YuLanjun Zhang
May 9, 2019·International Journal of Clinical Oncology·Xiaohong LiangChong Li
Feb 12, 2017·Oncology Reports·Kaidi LiShanqing Li
Jun 19, 2019·BMC Cancer·Wenfeng FangLi Zhang
Apr 3, 2020·Expert Review of Respiratory Medicine·Simona Scodes, Federico Cappuzzo
Jun 11, 2017·Oncology Letters·Pawel KrawczykMaciej Krzakowski
May 31, 2016·Cancer Science·Eri BannoKazuto Nishio
Mar 25, 2019·International Journal of Molecular Sciences·Alessandro RussoVincenzo Adamo
Apr 5, 2020·BMC Cancer·Mercedes Delgado-GarcíaMichele Biscuola
Aug 14, 2019·Pathology Oncology Research : POR·Hussein NassereddineAurélie Cazes
Jul 19, 2019·BMC Cancer·J ChantharasameeS Techawatanawanna
Nov 20, 2020·Thoracic Cancer·Kaiyan ChenYun Fan
Nov 16, 2016·ESMO Open·Teresa TroianiFortunato Ciardiello
Jan 10, 2020·Critical Reviews in Oncology/hematology·F PassigliaS Novello
Jan 17, 2020·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Eva Boysen Fynboe EbertPeter Meldgaard
Jan 14, 2020·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·James Chih-Hsin YangEdward S Kim
Mar 1, 2020·Cancer Treatment Reviews·Valerio GristinaAntonio Russo
Nov 28, 2017·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Hai-Yan TuYi-Long Wu
Apr 29, 2020·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Lei Deng, Haiying Cheng
Jun 8, 2021·Biochemical Pharmacology·Laura ScalviniRoberta Alfieri
Jun 29, 2021·Frontiers in Oncology·Yu WeiLiang Zeng
Sep 17, 2021·Nature·Jacqulyne P RobichauxJohn V Heymach
Sep 23, 2021·Scientific Reports·Chie MoritaYuichiro Ohe